在异质造血干细胞移植后B细胞复合的动态:现实研究
Guangyu Zhou1, Qian Zhan2, Lingle Huang1
1Department of Hematology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, P. R. China.
Journal of internal medicine
|March 4, 2024
概括
在全源造血干细胞移植 (allo-HSCT) 后B细胞复制对于患者的生存至关重要. 由于年龄和感染等因素的影响,B细胞恢复的延迟增加了死亡和复发的风险.
科学领域:
- 免疫学 免疫学 免疫学
- 血液学 血液学 血液学
- 移植医学 移植医学
背景情况:
- 免疫复合后异构造血造干细胞移植 (allo-HSCT) 对结果至关重要.
- B细胞是幽默免疫的关键,但它们在 allo-HSCT 后的复制动力学研究不足.
研究的目的:
- 在 allo-HSCT 后分析B细胞动态.
- 评估影响B细胞复制的因素.
- 为了将B细胞水平与生存相关联,并了解B细胞发育阶段.
主要方法:
- 分析了252名患者的B细胞动态,在合并-HSCT后2年内进行了分析.
- 评估影响B细胞复制的因素.
- 生存分析和倾向性得分匹配.
- 调解分析以探索年龄-B细胞-生存轴.
- 评估骨髓和外周血液子组中的B细胞发育阶段.
主要成果:
- 骨髓和外周血液中的B细胞复制显示出一致性.
- 延迟的B细胞恢复与男性性别,50岁以上的年龄,较老的捐赠者年龄,移植对宿主疾病和特定感染 (真菌,CMV) 有关.
- 较低的B细胞计数与死亡和复发风险的增加有关.
- 女性患者在1年后表现出优异的B细胞复制.
- 移植后12个月的B细胞复制调解了年龄对存活率的影响.
- 年轻的患者在骨髓中表现出更多不成熟的B细胞.
结论:
- B细胞复制是alo-HSCT结果的一个重要因素.
- 识别延迟B细胞恢复的因素可以指导干预.
- 了解年龄-B细胞-生存轴提供了治疗目标.
- 优化B细胞恢复管理可以提高alo-HSCT的疗效和安全性.
相关概念视频
B Cell Activation and Differentiation
1.7K
The adaptive immune response, a sophisticated defense mechanism, relies on the activation and differentiation of B lymphocytes, or B cells. These processes enable our bodies to mount a tailored response against specific pathogens such as bacteria, free virus particles, toxins, and parasites.
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
1.7K
Cells of the Adaptive Immune Response
986
The T and B lymphocytes of the adaptive immune system develop from common lymphoid progenitor cells in the bone marrow. These progenitors give rise to precursors that eventually develop into both T and B lymphocytes. As these precursors mature, they gain the ability to detect and respond to foreign antigens in the body, a process known as immunocompetence. Additionally, these precursors acquire self-tolerance, a process that ensures they do not react to self-antigens. This intricate system...
986
Multipotency of Hematopoietic Stem Cells
3.1K
The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
3.1K
Regulation of Hematopoietic Stem Cells
3.2K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.2K
Bone Marrow Sampling and Transplants
330
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
330
Hematopoiesis
5.3K
The process of blood cell formation is called hematopoiesis. Hematopoiesis starts early during development, on the seventh day of embryogenesis. This phase of hematopoiesis is called the primitive wave, wherein the extraembryonic yolk sac allows the production of erythroid cells and endothelial cells from a common precursor called hemangioblast. The erythroid cells provide oxygen to support the growth of the rapidly dividing embryo. Hemangioblasts later develop into hematopoietic stem cells or...
5.3K


